Explorethe depths of your imaging data
Medical images are only the tip of the iceberg. AI-enabled Radiomics allows you to see what's below the surface. Learn more in our Ebook, Seeing Below the Line. Get the eBook
Medical images aren’t just pictures. They’re data to dive into.
Consider that 90% of healthcare data is comprised of medical images, and each image holds quantitative descriptors of tumor structure and lesion characteristics which are not discernible to the human reader. Life science organizations are rudderless with an absence of this critical imaging data to inform clinical trials, monitor therapy response, and drive value-based clinical outcomes.
Without analyzing imaging data, you’re in the dark.
At HealthMyne, we are pioneers in applied radiomics, the cutting-edge field of extracting novel data and biomarkers from medical images. We extract quantitative features or descriptors and convert medical images into mineable data that goes beyond tumor size and burden.
We help life science organizations like yours access and easily translate ground-breaking radiomic insights into use in research, commercial strategies, and personalized health agendas.
We believe Radiomics is the next wave in healthcare, unleashing the hidden power of imaging data to speed drug and treatment development and the achievement of personalized medicine. When combined, radiomics, genomic and clinical data provide a holistic and powerful toolkit for tackling complex disease like cancer.
HealthMyne’s AI-enabled radiomic solution was leveraged in a retrospective study of soft tissue sarcoma patients with lung metastasis
Radiomics-based patient inclusion model improves clinical trail performance. Click below to read the full published research on how HealthMyne’s radiomic solution was leveraged by a leading research organization to determine that quantitative image analysis would have made a difference in clinical trial end points for soft tissue sarcoma patients.
Download our eBook
Seeing Below the Line
Learn how radiomics brings to light previously undiscoverable imaging data and unleashes a wealth of valuable information for life science organizations to evaluate disease progression, monitor therapy response and predict clinical outcomes. Equipped with this powerful information you can create a more precise profile of who is most likely to benefit from individualized therapy in the real world.
Get the Ebook to find out how you can dive deeper into your imaging data and see below the line.
Access our radiomic resources and insights to help guide you.
Radiomics-based patient inclusion model improves clinical trial performance
Read the full published research on how HealthMyne’s radiomic solution was leveraged by a leading research organization to determine...
Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients
HealthMyne was leveraged for lesion segmentation and automatic radiomic feature extraction. Identification of biomarkers allow for the appropriate stratification...
AI-enabled Radiomics Revolutionizes Cancer Research and Treatment on AWS
As an advanced medical imaging analytics solution, HealthMyne is critically dependent on highly available, scalable, and reliable infrastructure with...
Using ‘Imaging Analytics’ to Personalize Cancer Care
The adage, “A picture is worth a thousand words,” was first put forth at the turn of the 20th...
Seeing Below The Line Ebook | Chapter 4
Explore the promises of radiomics as it emerges as one of the most exciting developments in the life science...
Radiomic Solutions for Life Sciences
HealthMyne’s Radiomic Precision Metrics™ (RPM) and Radiomic Discovery Services
Our innovative AI and radiomic informed solutions can help your organization curate and digitize data from medical images as well as extract radiomic features to accelerate drug development and deliver real world evidence of therapy response. In addition, radiomic data can enhance and expand existing clinical trials and deliver precise endpoints to inform trial design, inclusion criteria and trial cohorts.
HealthMyne’s Radiomic Informed Therapy Response Module
HealthMyne provides radiomic informed workflow tools for documenting therapy and treatment response, ensuring appropriate clinical protocol assignment, disease progression monitoring and efficiently tracking patients through the trial process.
Analyze Real-World Evidence of Therapy Response
- Inform patient stratification and trial arm assignment
- Potential to increase trial availability
- Incorporate and automate trial protocol and reporting requirements
- Monitor disease progression and response to therapy
Enhance and Expand Existing Clinical Trials
- Incorporate radiomic insights in inclusion criteria and study design
- Leverage more precise and diverse endpoints for improved outcomes
- Measure radiomic data and response to therapy over time
Drive Value-based Clinical Outcomes
- Correlate clinical value and improved patient outcomes with therapy
- Transparency into patient population that will benefit from drug
- Support value-based contracting and reimbursement strategies